Healthcare & Medical Devices Global On demand · 24-48h

Global Vein Stripping Set Market Strategic Research Report

Global Vein Stripping Set Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Vein Stripping Set Market
$1762025
4.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Stainless Steel Wire, Nylons, Others

By Application: Vascular Surgery Operating Room, Vascular Intervention Center, Inpatient Surgical Ward, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: LeMaitre Vascular Inc., B. Braun Melsungen AG, Aesculap AG, Medtronic plc, Cook Medical LLC, Teleflex Incorporated, BD (Becton Dickinson and Company), Terumo Corporation, Getinge AB, KLS Martin Group, Integra LifeSciences Holdings Corp., Smith & Nephew plc, Zimmer Biomet Holdings Inc., Stryker Corporation, Cardinal Health Inc., Merit Medical Systems Inc., AngioDynamics Inc., Dispomedica GmbH, Accura Medizintechnik GmbH, Intra Special Catheters GmbH, Shanghai MicroPort Medical Group Co., Ltd., Shandong Weigao Group Medical Polymer Co., Ltd., Lepu Medical Technology (Beijing) Co., Ltd., Shinva Medical Instrument Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 152 pages
Market size 2025
$176
Million USD
Forecast CAGR
4.7%
2025-2032
Forecast 2032
$242.7
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Vein Stripping Set market size is predicted to grow from US$ 176 million in 2025 to US$ 257 million in 2032; it is expected to grow at a CAGR of 4.7% from 2026 to 2032.

A Vein Stripping Set is a surgical instrument system used for the treatment of varicose veins, particularly in the lower extremities. It typically consists of a flexible stripping wire, a detachable head, and guiding components designed to mechanically remove or extract diseased superficial veins from the body.

The device operates based on mechanical traction, where a stripping wire is inserted into the venous lumen and anchored distally. Controlled pulling forces are then applied to separate the vein from surrounding tissue layers. This requires high tensile strength, flexibility, and biocompatible material properties.Although increasingly replaced by endovenous ablation technologies, it remains widely used in traditional vascular surgery settings.

The vein stripping set market is undergoing a structural transformation driven by the increasing prevalence of venous insufficiency and aging populations. The rising incidence of varicose veins, associated with sedentary lifestyles and occupational strain, continues to sustain baseline demand for traditional surgical treatment tools such as vein stripping systems.

Although minimally invasive technologies such as radiofrequency ablation and laser closure are rapidly expanding, conventional vein stripping procedures remain widely used, particularly in developing regions and healthcare systems with limited access to advanced technologies. Improvements in material science and manufacturing processes have enhanced device flexibility, traction precision, and tissue safety, contributing to better surgical outcomes.

However, the market faces challenges from technological substitution, as endovenous ablation techniques progressively replace traditional mechanical stripping methods. Additionally, relatively low technical barriers in the mid- and low-end segments have led to intense price competition and margin pressure. Increasing regulatory requirements further raise compliance and development costs.

On the demand side, hospitals are shifting toward integrated vascular treatment solutions, driving demand for bundled surgical kits that include stripping devices, catheters, and auxiliary instruments. While long-term demand may decline in advanced markets, standardized treatment tools continue to see stable demand in primary healthcare systems.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vein Stripping Set market?

What factors are driving Vein Stripping Set market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vein Stripping Set market opportunities vary by end market size?

How does Vein Stripping Set break out by Type, by Application?

This report presents a comprehensive overview of the global Vein Stripping Set market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Stainless Steel Wire
  • Nylons
  • Others

Segment by Structural Design

  • Hook Type Stripper
  • Olive Tip Stripper
  • Wire Based Stripper

Segment by Target Vessel Type

  • Great Saphenous Vein Stripper
  • Small Saphenous Vein Stripper
  • Perforator Vein Stripper

Segment by Operation Type

  • Mechanical Vein Stripper
  • Hybrid Vein Extraction Kit
  • Minimally Invasive Vein Retrieval System

Segment by Application

  • Vascular Surgery Operating Room
  • Vascular Intervention Center
  • Inpatient Surgical Ward
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vein Stripping Set market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Vascular Surgery Operating Room, Vascular Intervention Center, Inpatient Surgical Ward evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Vein Stripping Set Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$176
2025
Forecast
$242.7
2032
CAGR
4.7%
2025–2032
Regionen
5
global
Key companies
LeMaitre Vascular Inc.B. Braun Melsungen AGAesculap AGMedtronic plcCook Medical LLCTeleflex IncorporatedBD (Becton Dickinson and Company)Terumo Corporation
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Stainless Steel WireNylonsOthers
By Application
Vascular Surgery Operating RoomVascular Intervention CenterInpatient Surgical WardOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Stainless Steel Wire
  • 3.1.3 Nylons
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Vascular Surgery Operating Room
  • 4.1.3 Vascular Intervention Center
  • 4.1.4 Inpatient Surgical Ward
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 LeMaitre Vascular Inc.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 B. Braun Melsungen AG
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Aesculap AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medtronic plc
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Cook Medical LLC
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Teleflex Incorporated
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 BD (Becton Dickinson and Company)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Terumo Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Getinge AB
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 KLS Martin Group
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Integra LifeSciences Holdings Corp.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Smith & Nephew plc
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zimmer Biomet Holdings Inc.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Stryker Corporation
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Cardinal Health Inc.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Merit Medical Systems Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 AngioDynamics Inc.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Dispomedica GmbH
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Accura Medizintechnik GmbH
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Intra Special Catheters GmbH
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Shanghai MicroPort Medical Group Co., Ltd.
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Shandong Weigao Group Medical Polymer Co., Ltd.
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Lepu Medical Technology (Beijing) Co., Ltd.
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Shinva Medical Instrument Co., Ltd.
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Vein Stripping Set market?
The global Vein Stripping Set market is estimated at US$ 176 million in 2025 (base year) and is projected to reach US$ 257 million by 2032.
What is the forecast CAGR for the Vein Stripping Set market?
The market is expected to grow at a CAGR of 4.7% from 2026 to 2032, expanding from US$ 176 million in 2025 to US$ 257 million in 2032, roughly 1.5 times its base-year value.
What is Vein Stripping Set?
A Vein Stripping Set is a surgical instrument system used for the treatment of varicose veins, particularly in the lower extremities. It typically consists of a flexible stripping wire, a detachable head, and guiding components designed to mechanically remove or extract diseased superficial veins from the body.
What are the main segments of the Vein Stripping Set market by type?
By type, the market is segmented into Stainless Steel Wire, Nylons and Others.
Which applications drive demand in the Vein Stripping Set market?
Key applications covered include Vascular Surgery Operating Room, Vascular Intervention Center, Inpatient Surgical Ward and Others.
Who are the key players in the Vein Stripping Set market?
Key players profiled include LeMaitre Vascular Inc., B. Braun Melsungen AG, Aesculap AG, Medtronic plc, Cook Medical LLC, Teleflex Incorporated, BD (Becton Dickinson and Company) and Terumo Corporation, among 24 companies covered in total.
Which regions and countries are covered for Vein Stripping Set?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Vein Stripping Set market?
The vein stripping set market is undergoing a structural transformation driven by the increasing prevalence of venous insufficiency and aging populations.
What challenges does the Vein Stripping Set market face?
However, the market faces challenges from technological substitution, as endovenous ablation techniques progressively replace traditional mechanical stripping methods.
Who should buy the Vein Stripping Set market report?
The report is intended for manufacturers and solution providers, distributors and end users in Vascular Surgery Operating Room, Vascular Intervention Center and Inpatient Surgical Ward, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Vein Stripping Set market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.